重症监护诊断市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

重症监护诊断市场按测试类型、最终用户(手术室、急诊室、重症监护室等)和地理位置细分

市场快照

 critical care diagnostics market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6 %
critical care diagnostics market growth

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

重症监护诊断市场的主要驱动力是全球慢性病和生活方式相关疾病的日益流行以及诊断技术的进步。根据健康图书馆的数据,据估计,美国约有 8400 万人患有某种形式的心血管疾病,每天造成约 2200 人死亡,平均每 40 秒就有 1 人死亡。

此外,人们对早期诊断和治疗的认识不断提高,通过与电子健康记录 (EHR) 的互操作性提高数据管理和连接的使用率,以及越来越多地采用远程医疗服务和远程通信,这些都是推动医疗保健增长的其他因素。重症监护诊断市场。然而,诊断测试的高成本和缺乏处理重症监护诊断的熟练专业人员可能会阻碍市场的增长。

报告范围

重症监护是指满足因危及生命的健康状况而需要立即关注的患者的需求,患者身体的重要器官有衰竭的风险。治疗需要先进的治疗、监测和诊断技术,目的是稳定器官功能并改善患者状况。

By Test Type
Flow Cytometry
Hematology Test
Microbiology and Infectious Test
Coagulation Test
Immunoprotein
Routine and Special Chemistry
Others
By End User
Operating Room
Emergency Room
Intensive Care Unit
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

急诊室有望引领市场

公众对推荐重症患者的急诊室的需求正在稳步上升。急诊科重症患者的生存率直接关系到疾病早期识别和治疗的推进。根据马里兰大学最近发表在《科学日报》上的 2017 年文章,急诊科提供的重症监护比例显着增加,美国近一半的医疗护理由急诊科提供。

根据美国卫生与公众服务部 2018 年的数据,2017 年,美国约有 18.6% 的成年人在过去 12 个月内接受过一次或多次急诊就诊。此外,在欧洲国家也可以观察到急诊室数量增加的类似模式,而在印度、中国和日本等新兴经济体中,数量差异很大。

此外,由于人口老龄化,事故和慢性病造成的伤害负担越来越重,预计这将推动预测期内重症监护诊断市场的增长。

 critical care diagnostics market trends

预计北美将在预测期内占据主导地位

北美一直在稳定增长,但地区差异很大。美国的医院对其手术室的物理基础设施进行了大量投资。美国医院 60% 以上的收入来自普通医院的手术室活动。

升级技术的需求对于重症监护诊断和管理仍然至关重要。这个因素伴随着长期住院的高成本,其中涉及手术室程序。医院本身的费用非常高。高额的医疗保健支出、更好的基础设施以及政府的额外参与预计将推动北美市场的增长。

critical care diagnostics market size

竞争格局

市场参与者通过资金和合作参与政府倡议,这可以帮助重症监护诊断市场获得显着增长。顶级参与者还参与新产品发布、合作伙伴关系、合作等,以提高他们的市场占有率。例如,2018 年 1 月,GE Healthcare 与罗氏建立了长期战略合作伙伴关系,共同为癌症和重症监护患者开发数字临床决策支持解决方案。市场上的主要参与者包括雅培、贝克曼-库尔特和罗氏等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in the Prevalence of Chronic Diseases and Lifestyle-related Disorders

      2. 4.2.2 Increase in Data Management and Connectivity through Interoperability to Electronic Health Record (EHR)

      3. 4.2.3 Rising Demand for Early Diagnosis and Treatment

      4. 4.2.4 Rising Adoption of Telehealth Services and Remote Communications

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Molecular Diagnostics Tools

      2. 4.3.2 Lack of Skilled Professionals

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Flow Cytometry

      2. 5.1.2 Hematology Test

      3. 5.1.3 Microbiology and Infectious Test

      4. 5.1.4 Coagulation Test

      5. 5.1.5 Immunoprotein

      6. 5.1.6 Routine and Special Chemistry

      7. 5.1.7 Others

    2. 5.2 By End User

      1. 5.2.1 Operating Room

      2. 5.2.2 Emergency Room

      3. 5.2.3 Intensive Care Unit

      4. 5.2.4 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott

      2. 6.1.2 Bayer AG

      3. 6.1.3 Becton, Dickinson & Company

      4. 6.1.4 bioMerieux SA

      5. 6.1.5 Bio-Rad Laboratories, Inc.

      6. 6.1.6 Chembio Diagnostic Systems, Inc.

      7. 6.1.7 Danaher Corporation

      8. 6.1.8 F. Hoffmann-La Roche

      9. 6.1.9 Siemens Healthineers

      10. 6.1.10 Sysmex Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Critical Care Diagnostics Market market is studied from 2018 - 2026.

The Critical Care Diagnostics Market is growing at a CAGR of 6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott, Becton, Dickinson & Company, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche, Siemens Healthineers are the major companies operating in Critical Care Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!